Synpromics is the leader in gene control, improving human health by enabling safer, more effective cell and gene medicines through proprietary genomics, bioinformatics and intelligent data driven design. Synpromics enables unprecedented control of gene expression through its ability to custom design synthetic cell-type, or condition, specific promoters. We achieve this by using proprietary technology and cutting edge techniques including sophisticated bioinformatics and screening approaches.